Literature DB >> 26424539

Non-motor symptoms and quality of life in patients with Parkinson's disease in Northeastern Mexico.

Ingrid Estrada-Bellmann1, Carlos R Camara-Lemarroy2, Hector J Calderon-Hernandez1, Jonathan J Rocha-Anaya1, Hector J Villareal-Velazquez1.   

Abstract

Parkinson's disease (PD) is a multisystem disorder, and besides the classical motor symptoms it is now known that patients also suffer from a variety of non-motor symptoms that adversely affect quality of life (QOL). Since data on Hispanic populations on this issue are scarce, our aim was to study the association of non-motor symptoms and QOL in patients with PD. This study is a cross-sectional observational study involving patients with PD using the following instruments: Quality of Life Questionnaire (PDQ-8), Unified Parkinson's Disease Rating Scale part III (UPDRS part III), and Non-Motor Symptom Scale (NMSS). We included 52 patients, with a median age of 64 years. Sleep/fatigue and mood/cognitive domains were the most common non-motor symptoms. Only sleep/fatigue, mood/cognition and gastrointestinal domains were associated with worse PDQ-8 scores. After adjusting for confounding variables, NMSS scores were significantly associated with a high PDQ-8 score. Higher NMSS scores were associated with and predicted higher PDQ-8 scores. The focus of management in PD should shift to a comprehensive strategy that incorporates care of non-motor symptoms and improves QOL.

Entities:  

Keywords:  Cognition; Non-motor symptoms; Parkinson’s disease; Quality of life; Sleep

Mesh:

Year:  2015        PMID: 26424539     DOI: 10.1007/s13760-015-0544-7

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  7 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

2.  An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients.

Authors:  Rejko Krüger; Paul Lingor; Triantafyllos Doskas; Johanna M L Henselmans; Erik H Danielsen; Oriol de Fabregues; Alessandro Stefani; Sven-Christian Sensken; Juan Carlos Parra; Koray Onuk; Ashley Yegin; Angelo Antonini
Journal:  Adv Ther       Date:  2017-06-19       Impact factor: 3.845

3.  The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson's Disease Patients.

Authors:  Dong-Woo Ryu; Joong-Seok Kim; Sang-Won Yoo; Yoon-Sang Oh; Kwang-Soo Lee
Journal:  J Mov Disord       Date:  2019-08-09

4.  Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson's disease, Isfahan, Iran.

Authors:  Mehri Salari; Ahmad Chitsaz; Masoud Etemadifar; Mohammad Reza Najafi; Omid Mirmosayyeb; Maryam Bemanalizadeh; Fatemeh Panahi; Hosna Mirzajani
Journal:  Iran J Neurol       Date:  2017-07-06

Review 5.  NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.

Authors:  Brigitte Vanle; William Olcott; Jaime Jimenez; Luma Bashmi; Itai Danovitch; Waguih William IsHak
Journal:  Transl Psychiatry       Date:  2018-06-15       Impact factor: 6.222

6.  Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease.

Authors:  Claudia Marisol Sánchez-Martínez; José Alberto Choreño-Parra; Noel Placencia-Álvarez; Lilia Nuñez-Orozco; Parménides Guadarrama-Ortiz
Journal:  Front Neurol       Date:  2019-11-14       Impact factor: 4.003

Review 7.  Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.

Authors:  Poornima D E Weerasinghe-Mudiyanselage; Mary Jasmin Ang; Sohi Kang; Joong-Sun Kim; Changjong Moon
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.